PMID- 23762245 OWN - NLM STAT- MEDLINE DCOM- 20140114 LR - 20221207 IS - 1932-6203 (Electronic) IS - 1932-6203 (Linking) VI - 8 IP - 6 DP - 2013 TI - Imputing amino acid polymorphisms in human leukocyte antigens. PG - e64683 LID - 10.1371/journal.pone.0064683 [doi] LID - e64683 AB - DNA sequence variation within human leukocyte antigen (HLA) genes mediate susceptibility to a wide range of human diseases. The complex genetic structure of the major histocompatibility complex (MHC) makes it difficult, however, to collect genotyping data in large cohorts. Long-range linkage disequilibrium between HLA loci and SNP markers across the major histocompatibility complex (MHC) region offers an alternative approach through imputation to interrogate HLA variation in existing GWAS data sets. Here we describe a computational strategy, SNP2HLA, to impute classical alleles and amino acid polymorphisms at class I (HLA-A, -B, -C) and class II (-DPA1, -DPB1, -DQA1, -DQB1, and -DRB1) loci. To characterize performance of SNP2HLA, we constructed two European ancestry reference panels, one based on data collected in HapMap-CEPH pedigrees (90 individuals) and another based on data collected by the Type 1 Diabetes Genetics Consortium (T1DGC, 5,225 individuals). We imputed HLA alleles in an independent data set from the British 1958 Birth Cohort (N = 918) with gold standard four-digit HLA types and SNPs genotyped using the Affymetrix GeneChip 500 K and Illumina Immunochip microarrays. We demonstrate that the sample size of the reference panel, rather than SNP density of the genotyping platform, is critical to achieve high imputation accuracy. Using the larger T1DGC reference panel, the average accuracy at four-digit resolution is 94.7% using the low-density Affymetrix GeneChip 500 K, and 96.7% using the high-density Illumina Immunochip. For amino acid polymorphisms within HLA genes, we achieve 98.6% and 99.3% accuracy using the Affymetrix GeneChip 500 K and Illumina Immunochip, respectively. Finally, we demonstrate how imputation and association testing at amino acid resolution can facilitate fine-mapping of primary MHC association signals, giving a specific example from type 1 diabetes. FAU - Jia, Xiaoming AU - Jia X AD - Harvard-MIT (Massachusetts Institute of Technology) Division of Health Sciences and Technology, Boston, Massachusetts, United States of America. FAU - Han, Buhm AU - Han B FAU - Onengut-Gumuscu, Suna AU - Onengut-Gumuscu S FAU - Chen, Wei-Min AU - Chen WM FAU - Concannon, Patrick J AU - Concannon PJ FAU - Rich, Stephen S AU - Rich SS FAU - Raychaudhuri, Soumya AU - Raychaudhuri S FAU - de Bakker, Paul I W AU - de Bakker PI LA - eng GR - 1R01AR062886-01/AR/NIAMS NIH HHS/United States GR - K08AR055688/AR/NIAMS NIH HHS/United States GR - 068545/Z/02/WT_/Wellcome Trust/United Kingdom GR - G1001799/MRC_/Medical Research Council/United Kingdom GR - U01 DK062418/DK/NIDDK NIH HHS/United States GR - R01 AR062886/AR/NIAMS NIH HHS/United States GR - G0000934/MRC_/Medical Research Council/United Kingdom GR - WT_/Wellcome Trust/United Kingdom GR - K08 AR055688/AR/NIAMS NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20130606 PL - United States TA - PLoS One JT - PloS one JID - 101285081 RN - 0 (Amino Acids) RN - 0 (HLA Antigens) RN - 0 (Histocompatibility Antigens Class I) RN - 0 (Histocompatibility Antigens Class II) SB - IM MH - Alleles MH - Amino Acids/*genetics/immunology MH - Chromosome Mapping MH - Diabetes Mellitus, Type 1/ethnology/*genetics/immunology MH - Genetic Predisposition to Disease MH - Genome-Wide Association Study MH - HLA Antigens/*genetics/immunology MH - HapMap Project MH - Haplotypes MH - Histocompatibility Antigens Class I/*genetics/immunology MH - Histocompatibility Antigens Class II/*genetics/immunology MH - Humans MH - Linkage Disequilibrium MH - *Polymorphism, Single Nucleotide MH - White People PMC - PMC3675122 COIS- Competing Interests: The authors have declared that no competing interests exist. EDAT- 2013/06/14 06:00 MHDA- 2014/01/15 06:00 PMCR- 2013/06/06 CRDT- 2013/06/14 06:00 PHST- 2013/02/14 00:00 [received] PHST- 2013/04/17 00:00 [accepted] PHST- 2013/06/14 06:00 [entrez] PHST- 2013/06/14 06:00 [pubmed] PHST- 2014/01/15 06:00 [medline] PHST- 2013/06/06 00:00 [pmc-release] AID - PONE-D-13-06894 [pii] AID - 10.1371/journal.pone.0064683 [doi] PST - epublish SO - PLoS One. 2013 Jun 6;8(6):e64683. doi: 10.1371/journal.pone.0064683. Print 2013.